Michael Carrier, a distinguished professor at Rutgers Law School widely regarded as a foremost authority on pharmaceutical antitrust law, appeared recently before the U.S. House Committee on Energy and Commerces Subcommittee on Health. The committee is considering bills aimed at curbing the ability of brand manufacturers to restrict access to drug samples, which are used by generic manufacturers to ensure that their products are identical to brand-name products. More.
|